News

PTLA

Portola Pharmaceuticals Inc. (PTLA) Drops 5.14% on January 06

Equities Staff | Equities.com |

Portola Pharmaceuticals Inc. (PTLA) was one of the Russell 2000's biggest losers for Wednesday January 06 as the stock slid 5.14% to $45.69, a loss of $-2.475 per share. Starting at an opening


Portola Pharmaceuticals Inc. (PTLA) Drops 7.95% on January 04

Equities Staff | Equities.com |

Portola Pharmaceuticals Inc. (PTLA) was one of the Russell 2000's biggest losers for Monday January 04 as the stock slid 7.95% to $47.36, a loss of $-4.09 per share. Starting at an opening price


Portola Pharmaceuticals Inc. (PTLA) Jumps 5.58% on December 23

Equities Staff | Equities.com |

Portola Pharmaceuticals Inc. (PTLA) was among the biggest gainers on the Russell 2000 for Wednesday December 23 as the stock popped 5.58% to $51.54, representing a gain of $2.725 per share. Some


Portola Pharmaceuticals Inc. (PTLA) is Trading Lower on Unusual Volume for December 21

Equities Staff | Equities.com |

Portola Pharmaceuticals Inc. (PTLA) experienced unusually high volume on Dec. 21, as the stock lost 1.82% to a closing price of $49.52. The stock saw 1.57 million shares trade hands over the


6 Biotech Opportunities Investors Can Maximize on By Using Options

The Life Sciences Report | Equities.com |

Volatility is the nature of the biotech beast, and it must be tamed or utilized to advantage. That's the philosophy of Eden Rahim, portfolio manager and option strategist at Theta Strategies


Playing the IPO Market: Getting In Before the Party Ends

Francis Gaskins | Equities.com |

In this week's interview with Francis Gaskins, Equities.com discusses some of the best recent performers and takes a look at what set them apart from the laggers. Gaskins also sheds some light on


World Economic Forum at Davos 2019 - Joseph Weinberg CEO PayCase, Chairman Shyft

Matt Bird sits down with Joseph Weinberg CEO PayCase, Chairman Shyft at the World Economic Forum at Davos 2019